White House Drone Advisor on the Future of Airspace Integration: Drones In America

 

While the COVID-19 pandemic has required politically divergent factions to work together, this election year continues to be a time of great division in our country.  Americans are experiencing heightened anxiety and economic uncertainty due to the COVID-19 pandemic, and they are looking to sources of strength, inspiration, and, above all, unity during this trying time.

Lisa Ellman, Executive Director of the Commercial Drone Alliance and Partner and Unmanned Aircraft Systems Practice Chair at Hogan Lovells, is one such source. 

In this episode of Drones in America, Grant sits down with Lisa Ellman who is widely considered a trailblazer and visionary in the commercial drone industry. Ellman reflects on her career in the industry that began with a series of jobs working for President Barack Obama’s administration (prior that that, President Obama was Ellman’s constitutional law professor at the University of Chicago!).

While President Obama’s administration commenced the initiative to integrate drones into the national airspace, President Trump’s administration has continued those efforts without regard to the political differences between the administrations.

Ellman says, “It’s absolutely a bipartisan issue – this isn’t something where political differences are stark in any way and, in, fact, I think we can all unite behind seeking to enable commercial drones and public use of drones in a way that benefits society for all of us.”

Foreseeing how important the commercial drone industry would become for the country, Ellman realized she could have even more of an impact by moving to the private sector, which led her to establish the UAS Practice at Hogan Lovells, as well as the Commercial Drone Alliance with Gretchen West, now President and CEO at Schiebel Aircraft.

In this episode, Ellman also discusses the importance of educating young girls and woman as to the increasingly import role they will play in the industry.  She also addresses the importance of gaining the public trust and the significant role remote identification will play in the integration of drones into the national airspace. 

Listen to all episodes of Drones In America!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More